Heron Therapeutics (HRTX) Earnings
|
Expand Research on HRTX
| Next EPS Date | 8/11/26 | EPS Growth Rate | +50.0% |
|---|---|---|---|
| Average EPS % Beat Rate | -237.5% | Revenue Growth Rate | +14.9% |
| Average % Move 1-Wk after EPS | -18.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/26  |
Q226 | N/A | -$0.01 | N/A | N/A | $42.73M | = | N/A | N/A | ||
| 5/11/26 | Q126 | -$0.04 | -$0.02 | -$0.02 | $34.7M | $39.28M | = |  | | Details | |
| 2/26/26 |
Q425 | N/A | -$0.02 | N/A | N/A | $39.83M | N/A | N/A | N/A | ||
| 11/4/25 | Q325 | -$0.10 | -$0.01 | -$0.09 | $38.2M | $39.49M | N/A | | | Details | |
| 8/8/25 |
Q225 | -$0.02 | -$0.01 | -$0.01 | $37.2M | $38.08M | N/A | | | Details | |
| 5/6/25 | Q125 | $0.01 | -$0.02 | +$0.03 | $38.9M | $34.25M | N/A | | | Details | |
| 2/27/25 | Q424 | $0.02 | -$0.03 | +$0.05 | $40.78M | $37.3M | = | | | Details | |
| 11/12/24 | Q324 | -$0.03 | -$0.04 | +$0.01 | $32.81M | $36.61M | = | | | Details |
